SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

73,123.83 -125.56
( -0.17%)

Global Indices

Nasdaq

52,230.09 -658.89
(-1.25%)

Dow Jones

7,644.13 -40.30
(-0.52%)

Hang Seng

62,584.98 -322.86
(-0.51%)

Nikkei 225

10,670.63 -54.40
(-0.51%)

Forex

USD-INR

94.61 0.10
(0.11%)

EUR-INR

106.18 0.08
(0.07%)

GBP-INR

126.70 0.19
(0.15%)

JPY-INR

0.60 0.00
(0.70%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sat Kartar Life Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

93343

INE0NB801022

43.3828165

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SATKARTAR

12.94

206.05

EPS(TTM)

Face Value()

Div & Yield %

10.08

0.53

Back

Vimta Labs standalone net profit rises 11.38% in the June 2026 quarter

Jul 20,2026

Net profit of Vimta Labs rose 11.38% to Rs 21.04 crore in the quarter ended June 2026 as against Rs 18.89 crore during the previous quarter ended June 2025. Sales rose 11.80% to Rs 109.07 crore in the quarter ended June 2026 as against Rs 97.56 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	109.07	97.56	12
OPM %	34.21	34.52	-
PBDT	40.88	35.11	16
PBT	28.33	25.25	12
NP	21.04	18.89	11

73,123.83 -125.56 ( -0.17%)

52,230.09 -658.89 (-1.25%)

7,644.13 -40.30 (-0.52%)

62,584.98 -322.86 (-0.51%)

10,670.63 -54.40 (-0.51%)

94.61 0.10 (0.11%)

106.18 0.08 (0.07%)

126.70 0.19 (0.15%)

0.60 0.00 (0.70%)